000 | 01213 a2200337 4500 | ||
---|---|---|---|
005 | 20250514233024.0 | ||
264 | 0 | _c20051128 | |
008 | 200511s 0 0 eng d | ||
022 | _a0022-3751 | ||
024 | 7 |
_a10.1113/jphysiol.2005.091777 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDuffield, Michael D | |
245 | 0 | 0 |
_aZinc inhibits human ClC-1 muscle chloride channel by interacting with its common gating mechanism. _h[electronic resource] |
260 |
_bThe Journal of physiology _cOct 2005 |
||
300 |
_a5-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aChloride Channels _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIon Channel Gating _xdrug effects |
650 | 0 | 4 | _aKidney |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aZinc _xpharmacology |
700 | 1 | _aRychkov, Grigori Y | |
700 | 1 | _aBretag, Allan H | |
700 | 1 | _aRoberts, Michael L | |
773 | 0 |
_tThe Journal of physiology _gvol. 568 _gno. Pt 1 _gp. 5-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1113/jphysiol.2005.091777 _zAvailable from publisher's website |
999 |
_c15658914 _d15658914 |